How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
36
HYFM Quote, Financials, Valuation and Earnings
Last price:
$0.62
Seasonality move
:
-8.61%
Day range:
$0.59 - $0.63
52-week range:
$0.43 - $1.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.14x
P/B ratio:
0.12x
Volume:
146.1K
Avg. volume:
162K
1-year change:
-31.46%
Market cap:
$28.3M
Revenue:
$226.6M
EPS (TTM):
-$1.41
Analysts' Opinion
-
Consensus RatingHydrofarm Holdings Group has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Hydrofarm Holdings Group has an estimated upside of 14.08% from its current price of $0.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.61.
Fair Value
-
According to the consensus of 0 analysts, Hydrofarm Holdings Group has 14.08% upside to fair value with a price target of -- per share.
HYFM vs. S&P 500
-
Over the past 5 trading days, Hydrofarm Holdings Group has underperformed the S&P 500 by -1.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hydrofarm Holdings Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hydrofarm Holdings Group revenues have been falling on a year-over-year basis for 11 quarters in a row. In the most recent quarter Hydrofarm Holdings Group reported revenues of $44M.
Earnings Growth
-
Hydrofarm Holdings Group has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Hydrofarm Holdings Group reported earnings per share of -$0.29.
Enterprise value:
120M
EV / Invested capital:
0.33x
Price / LTM sales:
0.14x
EV / EBIT:
--
EV / Revenue:
0.60x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-16.34x
Price / Operating cash flow:
5.15x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$38.7M
Return On Assets:
-13.24%
Net Income Margin (TTM):
-32.18%
Return On Equity:
-23.5%
Return On Invested Capital:
-16.46%
Operating Margin:
-20.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $393.4M | $240.9M | $200.2M | $54.2M | $44M | |
| Gross Profit | $48.5M | $28.7M | $38.7M | $3.3M | $8.5M | |
| Operating Income | -$71.6M | -$64.9M | -$37M | -$16.2M | -$9M | |
| EBITDA | -$223.7M | -$32.7M | -$16.8M | -$7.9M | -$1.3M | |
| Diluted EPS | -$5.82 | -$1.87 | -$1.41 | -$0.44 | -$0.29 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $142.9M | $222.5M | $186.7M | $133.9M | $103.4M | |
| Total Assets | $216.6M | $783M | $597.3M | $522.4M | $445.9M | |
| Current Liabilities | $92.8M | $118.6M | $48.7M | $35.4M | $31.9M | |
| Total Liabilities | $181.3M | $148M | $214.8M | $218.5M | $203M | |
| Total Equity | $35.3M | $635M | $382.5M | $303.9M | $243M | |
| Total Debt | $111.8M | $27.7M | $120.9M | $118.5M | $116.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$12.1M | $15.1M | -$4.6M | $7.7M | -$4.5M | |
| Cash From Investing | -$56.2M | -$5.2M | $1.3M | -$795K | -$819K | |
| Cash From Financing | $70.8M | $5.9M | -$4.9M | -$803K | -$711K | |
| Free Cash Flow | -$21.5M | $10M | -$7.3M | $6.9M | -$5.3M | |
HYFM
Sector
Market Cap
$28.3M
$764.9M
Price % of 52-Week High
51.13%
78.59%
Dividend Yield
0%
0%
Shareholder Yield
--
2.32%
1-Year Price Total Return
-34.01%
-1.49%
Beta (5-Year)
--
0.899
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.62
200-day SMA
Sell
Level
$0.72
Bollinger Bands (100)
Sell
Level
0.55 - 0.71
Chaikin Money Flow
Sell
Level
-43M
20-day SMA
Sell
Level
$0.68
Relative Strength Index (RSI14)
Sell
Level
42.46
ADX Line
Buy
Level
21.96
Williams %R
Neutral
Level
-74.5553
50-day SMA
Sell
Level
$0.65
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-44.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.8995)
Buy
CA Score
(Annual)
Level (-0.2903)
Buy
Beneish M-Score
(Annual)
Level (-3.3179)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.6149)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
Stock Forecast FAQ
In the current month, HYFM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HYFM average analyst price target in the past 3 months is --.
-
Where Will Hydrofarm Holdings Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hydrofarm Holdings Group share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Hydrofarm Holdings Group?
Analysts are divided on their view about Hydrofarm Holdings Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hydrofarm Holdings Group is a Sell and believe this share price will drop from its current level to --.
-
What Is Hydrofarm Holdings Group's Price Target?
The price target for Hydrofarm Holdings Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HYFM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hydrofarm Holdings Group is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HYFM?
You can purchase shares of Hydrofarm Holdings Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hydrofarm Holdings Group shares.
-
What Is The Hydrofarm Holdings Group Share Price Today?
Hydrofarm Holdings Group was last trading at $0.62 per share. This represents the most recent stock quote for Hydrofarm Holdings Group. Yesterday, Hydrofarm Holdings Group closed at $0.61 per share.
-
How To Buy Hydrofarm Holdings Group Stock Online?
In order to purchase Hydrofarm Holdings Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
